BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24369064)

  • 1. Ex vivo immunomodulatory effect of all-trans-retinoic acid during Behçet's disease: a study in Algerian patients.
    Djeraba Z; Boumedine K; Arroul-Lammali A; Otmani F; Belguendouz H; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):78-86. PubMed ID: 24369064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
    Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo all-trans retinoic acid modulates NO production and regulates IL-6 effect during rheumatoid arthritis: a study in Algerian patients.
    Arroul-Lammali A; Rahal F; Chetouane R; Djeraba Z; Medjeber O; Ladjouze-Rezig A; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2017 Apr; 39(2):87-96. PubMed ID: 28211306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans-retinoic acid modulates nitric oxide and interleukin-17A production by peripheral blood mononuclear cells from patients with Alzheimer's disease.
    Behairi N; Belkhelfa M; Mesbah-Amroun H; Rafa H; Belarbi S; Tazir M; Touil-Boukoffa C
    Neuroimmunomodulation; 2015; 22(6):385-93. PubMed ID: 26278415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of steroid hormones on the production of two inflammatory markers, IL-12 and nitric oxide, in Behçet's disease].
    Ahmedi ML; Belguendouz H; Messaoudene D; Mesbah-Amroun H; Terahi M; Lahlou-Boukoffa OS; Touil-Boukoffa C
    J Fr Ophtalmol; 2016 Apr; 39(4):333-40. PubMed ID: 27021132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro IL-18 production during uveitis associated with Behçet disease: effect of glucocorticoid therapy.
    Belguendouz H; Messaoudene D; Lahmar-Belguendouz K; Djeraba Z; Otmani F; Terahi M; Tiar M; Hartani D; Lahlou-Boukoffa OS; Touil-Boukoffa C
    J Fr Ophtalmol; 2015 Mar; 38(3):206-12. PubMed ID: 25630753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.
    Mumcu G; Inanç N; Özdemir FT; Tulunay A; Ekşioğlu-Demiralp E; Ergun T; Direskeneli H
    Int J Dermatol; 2013 Dec; 52(12):1561-6. PubMed ID: 23879671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.
    Djaballah-Ider F; Djeraba Z; Chemli M; Dammene-Debbihe N; Lounis D; Belguendouz H; Medour Y; Chaib S; Touil-Boukoffa C
    Inflammopharmacology; 2018 Jun; 26(3):725-735. PubMed ID: 29600486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS-induced Src family kinases activity mediates IL-10 production through activation of STAT3 in peripheral blood mononuclear cells of patients with Behçet's Disease.
    Irtegun Kandemir S; Tekin MA; Bozkurt M; Dagli AZ; Kalkanli-Tas S
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):116-121. PubMed ID: 29096751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
    Chekaoui A; Belguendouz H; Lahmar K; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Int Immunopharmacol; 2020 Mar; 80():106119. PubMed ID: 31927504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10.
    Belguendouz H; Messaoudène D; Lahmar K; Ahmedi L; Medjeber O; Hartani D; Lahlou-Boukoffa O; Touil-Boukoffa C
    J Interferon Cytokine Res; 2011 Sep; 31(9):643-51. PubMed ID: 21510811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
    Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X; Wang C; Ye Z; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
    Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study.
    Yalcin B; Atakan N; Alli N
    Clin Exp Dermatol; 2008 Aug; 33(5):629-33. PubMed ID: 18616724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
    Sim JH; Park MJ; Park S; Lee ES
    Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin modulates the NF-κb pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women.
    Giorgi VS; Peracoli MT; Peracoli JC; Witkin SS; Bannwart-Castro CF
    J Reprod Immunol; 2012 Sep; 95(1-2):67-72. PubMed ID: 22871551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.